NIH’s “competitive but not discussed” designation reflects review compression, not automatic rejection, and still carries real funding potential.
Archives
NIH Deadlines Are Predictable. Strategy Is Not.
NIH deadlines are predictable, but strategy is not. Early signals shape funding outcomes long before SBIR/STTR applications are submitted.
How NSF’s New DSMP Rules Change the Way Proposals Are Evaluated
NSF’s DSMP update signals a deeper shift, reviewers now assess execution readiness through data plans, not just technical merit.
Evaluation Still Matters, Even When a Grant Doesn’t Require an External Evaluator
Some federal grants do not require external evaluators. That does not mean evaluation disappears. Smart applicants still plan how results will be measured.
How to understand the difference between NIH Highlighted Topics and Funding Opportunities
NIH clarifies the difference between Highlighted Topics and Funding Opportunities. Misunderstanding the distinction can undermine proposal success.
How to Navigate New NSF Review Rules Without Losing Your Shot at Funding
NSF rule changes raise the bar on proposal readiness. One weak submission can now close doors. Here is how to respond.
How to understand NIH emergency peer-review modifications and why they matter right now
NIH introduced emergency peer-review modifications that affect evaluation, timelines, and committee operations. Here is what applicants need to know.
NIH Hits Pause on SBIR and STTR: What the Latest Guidance Means for Your Funding Strategy
NIH abruptly paused SBIR and STTR activity, creating uncertainty for applicants who now require strategy, preparation, and airtight compliance more than ever.